Cambridgeshire and Peterborough
Formulary
 
back
9 Nutrition and blood
09-01-01-02 Parenteral iron

Iron Isomaltoside Monofer®, Diafer®
Restricted

  • CUHFT: First line treatment:  


    • Diafer® 5% or 50mg/ml. Approved and in use in dialysis and haemodialysis patients who administer at home.

    • Monofer®: 10% or 100ml/ml. All specialities. If patient experiences a true allergy conifrmed by mast cell triptase repsonse - then Venofer® will be recommend. There may be a small cohort of patients  who experiences severe side effects to Monofer but are not allergic to it and Ferinject may be appropriate.


  • RPH: Monofer®: For use by Thoracic Directorate and Cardiac Anaemia Clinic. (1st line parenteral iron formulation at RPH

  • Non formulary at all other Trusts


 

Link  MedCalc: Ideal body weight calculator
 

Restricted Drug Red Hospital View adult BNF  View SPC online  View childrens BNF
Iron Sucrose Venofer®
Restricted

  • CUHFT: Restricted to patient with a historically allergy to Cosmofer or Monofer

  • NWAFT: Restricted to use by renal team only

  • RPH: For use by RSSC in Restless Leg Syndrome


Restricted Drug Red Hospital View adult BNF  View SPC online  View childrens BNF
Ferric Carboxymaltose Ferinject®
Restricted

 



  • NWAFT: Restricted to where a faster infusion is required

  • RPH: Formulary

  • Non-formulary at all other Trusts


Restricted Drug Red Hospital View adult BNF  View SPC online  View childrens BNF
Iron Dextran CosmoFer®
Restricted

  • NWAFT: Formulary

  • Non-formulary at all other Trusts

Link  UKMI Q&A: How do I use Cosmofer (iron dextran) total dose infusion for correction of iron deficiency anaemia
 

Restricted Drug Red Hospital View adult BNF  View SPC online  View childrens BNF